ScoreWhy is Sichuan Goldstone Asia Pharmaceutical, Inc. ?
1
Poor Management Efficiency with a low ROCE of 7.80%
- The company has been able to generate a Return on Capital Employed (avg) of 7.80% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 3.75% and Operating profit at 56.69% over the last 5 years
3
Positive results in Sep 25
- NET PROFIT(HY) At CNY 31.11 MM has Grown at 193.82%
- RAW MATERIAL COST(Y) Fallen by -24.66% (YoY)
4
With ROE of 4.44%, it has a fair valuation with a 1.53 Price to Book Value
- Over the past year, while the stock has generated a return of 4.37%, its profits have risen by 53.7% ; the PEG ratio of the company is 0.6
- At the current price, the company has a high dividend yield of 0.4
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sichuan Goldstone Asia Pharmaceutical, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sichuan Goldstone Asia Pharmaceutical, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sichuan Goldstone Asia Pharmaceutical, Inc.
9.78%
0.37
44.48%
China Shanghai Composite
13.33%
0.90
14.74%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.75%
EBIT Growth (5y)
56.69%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.45
Tax Ratio
21.22%
Dividend Payout Ratio
30.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.80%
ROE (avg)
5.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.53
EV to EBIT
26.77
EV to EBITDA
15.00
EV to Capital Employed
1.59
EV to Sales
3.38
PEG Ratio
0.64
Dividend Yield
0.36%
ROCE (Latest)
5.94%
ROE (Latest)
4.44%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
At CNY 31.11 MM has Grown at 193.82%
RAW MATERIAL COST(Y)
Fallen by -24.66% (YoY
-5What is not working for the Company
NET SALES(Q)
At CNY 216.79 MM has Fallen at -19.11%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.34 times
Here's what is working for Sichuan Goldstone Asia Pharmaceutical, Inc.
Net Profit
At CNY 31.11 MM has Grown at 193.82%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -24.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sichuan Goldstone Asia Pharmaceutical, Inc.
Net Sales
At CNY 216.79 MM has Fallen at -19.11%
over average net sales of the previous four periods of CNY 268.02 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 2.34 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
